These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 11140428

  • 1. Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.
    Brindley C, Falcoz C, Mackie AE, Bye A.
    Clin Pharmacokinet; 2000; 39 Suppl 1():1-8. PubMed ID: 11140428
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
    Mackie AE, McDowall JE, Falcoz C, Ventresca P, Bye A, Daley-Yates PT.
    Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C, Horton J, Mackie AE, Harding SM, Daley-Yates PT.
    Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
    [Abstract] [Full Text] [Related]

  • 4. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE, McDowall JE, Ventresca P, Bye A, Falcoz C, Daley-Yates PT.
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [Abstract] [Full Text] [Related]

  • 5. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A, Bareille PJ, Rousell VM.
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [Abstract] [Full Text] [Related]

  • 6. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [Abstract] [Full Text] [Related]

  • 7. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C, Li B, Tattam B, Brown K, Seale JP, Donnelly R.
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [Abstract] [Full Text] [Related]

  • 9. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ.
    Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
    [Abstract] [Full Text] [Related]

  • 10. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
    Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR.
    Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
    [Abstract] [Full Text] [Related]

  • 11. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability of orally administered micronised fluticasone propionate.
    Falcoz C, Oliver R, McDowall JE, Ventresca P, Bye A, Daley-Yates PT.
    Clin Pharmacokinet; 2000 Feb; 39 Suppl 1():9-15. PubMed ID: 11140434
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma.
    Daley-Yates PT, Tournant J, Kunka RL.
    Clin Pharmacokinet; 2000 Feb; 39 Suppl 1():39-45. PubMed ID: 11140432
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M, Song S, Steinfeld J.
    Allergy Asthma Proc; 2015 Feb; 36(5):365-71. PubMed ID: 26314817
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [Abstract] [Full Text] [Related]

  • 17. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
    Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler.
    Mehta R, Daley-Yates PT, Jenkins K, Bianco J, Stylianou A, Louey MD, Chan RH.
    Pulm Pharmacol Ther; 2014 Oct 12; 29(1):66-73. PubMed ID: 25035069
    [Abstract] [Full Text] [Related]

  • 19. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L, Pedersen S.
    Am J Respir Crit Care Med; 2003 Oct 01; 168(7):779-82. PubMed ID: 12893646
    [Abstract] [Full Text] [Related]

  • 20. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG.
    J Asthma; 1998 Oct 01; 35(4):337-45. PubMed ID: 9669827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.